Metsera Raises $215m, Bringing 2024 Total To $505m For Obesity Trials

Series B Round Comes Seven Months After Launch

 
• By Mandy Jackson
  
Metsera is stepping up its investment in its obesity pipeline (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Scrip